Pharmaceutical Industry

Page 17 of 100

Alphabet’s Isomorphic Labs to collaborate with Novartis, Lilly on AI-driven drug discovery
Health

Alphabet’s Isomorphic Labs to collaborate with Novartis, Lilly on AI-driven drug discovery

By Susanne Barton and Bloomberg
January 8, 2024
Boston Scientific headquarters as pictured on Jan. 19, 2007. The company acquired device-maker Axonics Inc. for $2.7 billion on Monday.
Health

J&J, Merck, Boston Scientific go on $6.4B buying spree

By Fiona Rutherford and Bloomberg
January 8, 2024
Eli Lilly and Company says its popular drugs Mounjaro and Zepbound, also known as GLP-1s, are not meant for those without obesity or type 2 diabetes.

Eli Lilly cracks down on the use of weight loss drugs Mounjaro and Zepbound for ‘cosmetic’ reasons instead of for diabetes and obesity

By
January 4, 2024
Ozempic, Wegovy demand so strong Europe’s most valuable listed company plans ‘mega manufacturing facility’
Health

Ozempic, Wegovy demand so strong Europe’s most valuable listed company plans ‘mega manufacturing facility’

By Ellie Harmsworth and Bloomberg
December 24, 2023
Pharma will pay rebates in 2024 on 48 drugs whose prices rose more than inflation this year: ‘Let’s call this for what it is—it simply is a rip off’
Health

Pharma will pay rebates in 2024 on 48 drugs whose prices rose more than inflation this year: ‘Let’s call this for what it is—it simply is a rip off’

By Amanda Seitz and The Associated Press
December 15, 2023
Why business should pay attention to the Supreme Court’s latest mifepristone case
Newsletters

Why business should pay attention to the Supreme Court’s latest mifepristone case

By Emma Hinchliffe and Joey Abrams
December 14, 2023
Climate change is unleashing a tsunami of infectious diseases–and we have fewer and fewer drugs that can treat them
Commentary

Climate change is unleashing a tsunami of infectious diseases–and we have fewer and fewer drugs that can treat them

By
December 11, 2023
Joe Biden
Politics

The White House threatens to cancel the patents of taxpayer-funded drugs if they’re too expensive for patients to afford

By Amanda Seitz, Zeke Miller and The Associated Press
December 7, 2023
Eli Lilly’s CFO explains why the company’s newest weight-loss drug Zepbound will cost 20% less than the current options
Newsletters

Eli Lilly’s CFO explains why the company’s newest weight-loss drug Zepbound will cost 20% less than the current options

By
November 29, 2023
McLaren Racing boss Zak Brown
Leadership

How the high-stakes world of Formula 1 racing inspired Sanofi CEO Paul Hudson to deliver more medicines

By
November 27, 2023
Biden administration is cracking down on pharmacy middlemen, but they’re so powerful it might be too late to help independent drugstores
Finance

Biden administration is cracking down on pharmacy middlemen, but they’re so powerful it might be too late to help independent drugstores

By Arthur Allen and KFF Health News
November 16, 2023
Our changing climate is jeopardizing worker health and productivity. Companies need to adapt their operations
Commentary

Our changing climate is jeopardizing worker health and productivity. Companies need to adapt their operations

By Martine Ferland and Judy Monroe
November 15, 2023
Europe’s most valuable drugmaker Novo Nordisk is threatening the EU with a shift to the U.S.
Health

Europe’s most valuable drugmaker Novo Nordisk is threatening the EU with a shift to the U.S.

By
November 6, 2023
Just 1 sleepless night could actually lead to a dopamine boost—and reverse depression for several days
Mind

Just 1 sleepless night could actually lead to a dopamine boost—and reverse depression for several days

By
November 3, 2023
picture of four wegovy injections lined up
Health

Novo Nordisk isn’t alone: Sales of Ozempic rival Mounjaro explode as drugmaker Eli Lilly profits from Americans’ weight-loss craze

By
November 3, 2023

Most Popular